🏛️ Verified NIH Record • Updated 2026-08-27
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease (NCT00606346)
🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Janssen Biotech, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the long-term safety and clinical status of pediatric patients with Inflammatory Bowel Disease (IBD). Particular attention will be directed to recording safety outcomes reported in association with infliximab and other prescribed IBD therapies. In addition, information on disease status and quality of life will be collected.
Who can join: Review the eligibility criteria below.
Location: Clinical Research Facility — Mobile, Alabama
Age range: 1 Month to 17 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (62 Sites)
Showing the first 25 of 62 sites.
- Clinical Research Facility — Mobile, Alabama
- Clinical Research Facility — Phoenix, Arizona
- Clinical Research Facility — Los Angeles, California
- Clinical Research Facility — Oakland, California
- Clinical Research Facility — Sacramento, California
- Clinical Research Facility — San Diego, California
- Clinical Research Facility — San Francisco, California
- Clinical Research Facility — Aurora, Colorado
- Clinical Research Facility — Hartford, Connecticut
- Clinical Research Facility — New Haven, Connecticut
- Clinical Research Facility — Gainesville, Florida
- Clinical Research Facility — Miami, Florida
- Clinical Research Facility — Orlando, Florida
- Clinical Research Facility — Atlanta, Georgia
- Clinical Research Facility — Boise, Idaho
- Clinical Research Facility — Chicago, Illinois
- Clinical Research Facility — Lexington, Kentucky
- Clinical Research Facility — New Orleans, Louisiana
- Clinical Research Facility — Portland, Maine
- Clinical Research Facility — Boston, Massachusetts
- Clinical Research Facility — Newton, Massachusetts
- Clinical Research Facility — Worcester, Massachusetts
- Clinical Research Facility — Detroit, Michigan
- Clinical Research Facility — Southfield, Michigan
- Clinical Research Facility — Minneapolis, Minnesota
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Crohn's Disease
- A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD) — Birmingham, Alabama
- A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease — Birmingham, Alabama
- A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease. — Sun City, Arizona
- Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice. — Blacktown, New South Wales
- Transmural Healing and Disease-Modifying Effect of Guselkumab in Crohn's Disease Patients — San Francisco, California
- Dietary Therapy and Gut Microbiome in Crohn's Disease and Ulcerative Colitis — Boston, Massachusetts
Explore by condition: All Crohn's Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.